BRIEF-Implanet granted ANVISA regulatory approval in Brazil to market the JAZZ Band platform

martes 3 de noviembre de 2015 13:36 GYT

Nov 3 (Reuters) - Implanet SA :

* Announces that it has received regulatory approval from the Brazilian National Health Surveillance Agency (ANVISA) to market its JAZZ Band platform Source text for Eikon: Further company coverage: (Gdynia Newsroom)